Bruker Launches FluoroType® SARS-CoV-2/Flu/RSV PCR Panel in Europe with CE-IVD Mark

Winter four-plex panel detects clinically most important respiratory viruses SARS-CoV-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) Validation with nasopharyngeal swabs and oropharyngeal swabs for highest sensitivity Saliva sampling option convenient for patients, while also achieving high PCR sensitivity; saliva samples do not require extraction and enable a faster, resource-effective workflow NEHREN, Germany–(BUSINESS... Read more

SARS-CoV-2 Viral Genome Sequencing Data Presented from Research Using Pacific Biosciences Technology

MENLO PARK, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced initial findings from the company’s research collaboration with Labcorp that is focused on SARS-CoV-2 and the related immune response to COVID-19. Announced in April 2020, PacBio and... Read more

SARS-CoV-2 Viral Genome Sequencing Data Presented from Research Using Pacific Biosciences Technology

Presentation at the American Society for Microbiology NGS Conference highlights utility of PacBio’s highly accurate long-read sequencing platform in disease surveillance Presentation at the American Society for Microbiology NGS Conference highlights utility of PacBio’s highly accurate long-read sequencing platform in disease surveillance Read more

Dr. Ana K. Stankovic, MD, PhD, Appointed to Fluidigm Board of Directors

December 15, 2020 SOUTH SAN FRANCISCO, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the appointment of Dr. Ana K. Stankovic, MD, PhD, MSPH, to the company’s Board of Directors. Dr. Stankovic is a seasoned leader with more than 30 years of research... Read more

Oxford Nanopore and SourceBio announce commercial partnership for UK COVID-19 testing service

Tue 15th December 2020 Oxford Nanopore’s rapid LamPORE COVID-19 test to be made available via SourceBio accredited lab facilities. Oxford Nanopore Technologies Limited (“Oxford Nanopore”), a leading next generation DNA/RNA sequencing technology company and SourceBio International plc (“SourceBio”), an international provider of integrated state of the art laboratory services and products, announce a strategic commercial... Read more

EUROIMMUN Receives CE Mark for New PCR Test to Differentiate Between COVID-19 and Flu

Company expands testing portfolio for acute diagnostics of COVID-19 WALTHAM, Mass. – December 14, 2020 – EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the CE marked EURORealTime SARS-CoV-2/Influenza A/B for direct detection of SARS-CoV-2, influenza virus type A and influenza virus type B. It expands the testing portfolio for acute COVID-19 diagnostics... Read more

Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads

MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that three of the United Kingdom’s leading core laboratories have increased their investment in the company’s Single Molecule, Real-Time (SMRT®) Sequencing technology. Edinburgh Genomics, Oxford Genomics Centre,... Read more

Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads

Edinburgh Genomics, Oxford Genomics Centre, and University of Liverpool Centre for Genomic Research have added new PacBio Sequel II & IIe Systems to their service laboratories Edinburgh Genomics, Oxford Genomics Centre, and University of Liverpool Centre for Genomic Research have added new PacBio Sequel II & IIe Systems to their service laboratories Read more

Weston Umstead, Ph.D. Promoted to Technology & Business Development Manager for Chiral Technologies, Inc.

Posted December 10, 2020 For Immediate Release  Weston Umstead, Ph.D. Promoted to Technology & Business Development Manager for Chiral Technologies, Inc. WEST CHESTER, Pa (December 10, 2020) — Chiral Technologies, Inc. today announced the promotion of Weston Umstead, Ph.D., as the company’s new Technology and Business Development Director. Umstead joined Chiral Technologies in 2016 as... Read more